What is the equity of Cerus this year?
Cerus has equity of 52.65 M USD this year.
Cerus Equity 2024
Cerus Equity
52.65 M USD
Cerus Dividend yield
Ticker
CERS
ISIN
US1570851014
WKN
905249
In 2024, Cerus's equity was 52.65 M USD, a -22.12% increase from the 67.6 M USD equity in the previous year.
Cerus Aktienanalyse
What does Cerus do?
Cerus Corporation is a biotechnology company specialized in the development and marketing of products for the processing and transfusion of blood products. The company was founded in 1991 and is headquartered in Concord, California. Cerus Corporation is listed on the NASDAQ stock exchange and employs approximately 450 employees worldwide. The history of Cerus Corporation began when its founder, Stephen Isaacs, received a blood transfusion and subsequently became infected with the Hepatitis B virus. This incident inspired him to start a company focusing on the development of technologies for the safe transfusion of blood products. In 1993, Cerus Corporation introduced its first product, the Intercept Blood System. This system utilized ultraviolet light and chemicals to deactivate pathogens such as viruses, bacteria, and parasites in blood. The business model of Cerus Corporation revolves around the development and distribution of products for medical needs. The company's focus is on the processing of blood products such as platelets, plasma, and red blood cells to reduce the risk of infectious diseases and other potentially harmful side effects in blood transfusions. Cerus also provides training and technical support for its products. Cerus Corporation has several divisions, including the Intercept Blood System, Blood Center Technology, and Innovative Technology. The Intercept Blood System division is the largest and most popular, offering products such as the Intercept Blood System for platelets and plasma, the Intercept Blood System for red blood cells, the Intercept Blood System for PAS (reduced volume blood bank) and the Intercept Blood System for Fresh Frozen Plasma. Cerus Corporation's Blood Center Technology division provides technologies and devices for blood banks and transfusion services, including transfusion safety systems and blood testing devices. The Innovative Technology division specializes in the development of new technologies and products. Another product of Cerus Corporation is INTERCEPT FDA Approved Plasma, which was approved by the US Food and Drug Administration (FDA) in 2018. The plasma is made from donated blood and processed using the INTERCEPT technology. The INTERCEPT technology decontaminates various blood components, increasing their safety in transfusions. Cerus Corporation has achieved significant success in the medical technology industry. Cerus Corporation's Intercept Blood System is approved in more than 25 countries and has helped save countless lives and prevent diseases for healthcare professionals and patients. The company has been recognized multiple times for its innovative products and services, including receiving the Gold Medal at the Edison Awards in 2017 and the Technology Pioneer Award from the World Economic Forum in 2016. In summary, Cerus Corporation is a successful biotechnology company that develops and distributes innovative technologies for the processing and transfusion of blood products. Through its technology and products, Cerus contributes to increasing the safety of blood transfusions by reducing the risk of infectious diseases and other potentially dangerous side effects. Cerus Corporation will continue to play an important role in the medical technology industry in the future. Cerus ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Cerus's Equity
Cerus's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Cerus's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Cerus's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Cerus's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Cerus’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Cerus Stock
What was the equity of Cerus compared to the previous year?
The equity of Cerus has increased/decreased by -22.12% decreased compared to the previous year.
What impact does a high equity have on investors of Cerus?
A high equity is advantageous for investors of Cerus as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Cerus?
A low equity can be a risk for investors of Cerus, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Cerus affect the company?
An increase in equity of Cerus can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Cerus affect the company?
A reduction in equity of Cerus can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Cerus?
Some factors that can affect the equity of Cerus include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Cerus so important for investors?
The equity of Cerus is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Cerus take to change the equity?
To change equity, Cerus can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Cerus pay?
Over the past 12 months, Cerus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cerus is expected to pay a dividend of 0 USD.
What is the dividend yield of Cerus?
The current dividend yield of Cerus is .
When does Cerus pay dividends?
Cerus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Cerus?
Cerus paid dividends every year for the past 0 years.
What is the dividend of Cerus?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Cerus located?
Cerus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cerus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cerus from 6/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/2/2024.
When did Cerus pay the last dividend?
The last dividend was paid out on 6/2/2024.
What was the dividend of Cerus in the year 2023?
In the year 2023, Cerus distributed 0 USD as dividends.
In which currency does Cerus pay out the dividend?
The dividends of Cerus are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cerus
Our stock analysis for Cerus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cerus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
